Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure

Clinical trial NCT05165290 · UNKNOWN

Trial details

NCT number: NCT05165290
Sponsor: TearClear Corp
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Elevated Intraocular Pressure

Start date: 2021-11-29
Primary completion: 2022-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.